Navigation Links
ERT to Present at the UBS 20th Annual Global Healthcare Services Conference on February 8, 2010
Date:2/1/2010

PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), announced today that Dr. Michael J. McKelvey, the Company's President and CEO, and Keith Schneck, the Company's Executive Vice President and CFO, are scheduled to present at the UBS 20th Annual Global Healthcare Services Conference at 3:30 PM EST on February 8, 2010 in New York City.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com.  The webcast may also be accessed at http://cc.talkpoint.com/ubsx001/020810a_ke/?entity=33_YR2H1UU.  The webcast will be available via replay for 90 days.

About ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com) is a global provider of technology and services to the biopharmaceutical, medical device, and related industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements.  These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

SOURCE ERT

RELATED LINKS
http://www.ert.com

'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
2. Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conference
3. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
4. NeurogesX to Present at J.P. Morgan Health Care Conference
5. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
6. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
7. Resverlogix Presenting at Biotech Showcase
8. Amira Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
9. Profectus Biosciences to Present at Key Investor Conference in January 2010
10. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
11. Institut Paoli Calmettes and Ipsogen Presented a New Study Supporting the Pivotal Role of Tumor Grade in Chemotherapy Prescription at the 32nd Annual San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Baltimore, Maryland (PRWEB) , ... December 07, 2016 ... ... platform for digital pathology, announced today a new service to enable rapid migration ... in data upload has remained one of the factors limiting adoption of digital ...
(Date:12/6/2016)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... and fiscal year ended September 30, 2016. ... , , ... diagnostics company that develops and commercializes proprietary technologies and products for ... Achieved revenues of $1.4 million more than tripling prior years revenue. ...
(Date:12/6/2016)... ... December 06, 2016 , ... Symbios Technologies, Inc. ... the company has engaged in a collaborative research partnership with Colorado State University ... Office of the Vice President for Research. This agreement is designed to further ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International ... $150 million from the National Institutes of Health,s ... the Division of AIDS (NIAID-DAIDS) to support the ... non-vaccine pre-exposure (PreP) agents. Under the seven-year contract, ... product development services for candidate HIV-prevention products that ...
Breaking Biology Technology:
(Date:11/15/2016)... Research and Markets has announced the addition of the "Bioinformatics ... ... The global bioinformatics market is projected ... in 2016, growing at a CAGR of 21.1% during the forecast ... by the growing demand for nucleic acid and protein sequencing, increasing ...
(Date:11/14/2016)... SANTA CLARA, Calif. , Nov. 14, ... of the biometric identification market, Frost & ... Global Frost & Sullivan Award for Visionary ... leading player in the biometric identification market ... a multi-modal verification solution for instant, seamless, ...
(Date:6/22/2016)... , June 22, 2016  The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...
Breaking Biology News(10 mins):